Hormone Replacement Therapy (HRT) is a long-standing medical therapy that is implemented when the body is unable to produce enough hormones or when hormones are required to be raised or lowered to improve health and well-being. Hormones are important in controlling the growth, metabolism, mood, sexual development, bone density, and general body stability. The hormones are capable of causing a great deal of physical and psychological anguish when they are out of the parameters of healthy ranges. HRT is effective because it replaces the lack of hormones with specific levels of hormones, including estrogen, progesterone, testosterone, or thyroid hormones. This medication is decades old, and it is a safe form of treatment that is still considered a common practice in modern medicine.

The use of HRT is often prescribed in a wide variety of medical diseases and life stages. Hot flashes, sleep disturbances, mood changes, and bone loss are some of the symptoms that many women treat with HRT during menopause or at an early age of menopause. Men who have clinically low testosterone levels can be put on hormone therapy to deal with fatigue, depression, loss of libido, and muscle wasting. One of the most common, long-term treatments that is administered worldwide and is a necessity to individuals whose thyroid glands fail to operate effectively is thyroid hormone replacement. HRT practices are also applied in post-cancer therapies when the reproductive organs have been removed, some conditions involving puberty, intersex differences, serious forms of polycystic ovary syndrome (PCOS), and endometriosis. In all these, HRT is considered normal, required healthcare.

In the case of transgender individuals, HRT is treated as a gender-affirming medical intervention. This type of HRT is used to alleviate gender dysphoria, meaning the distress caused by the fact that the physical features of a person do not correspond with their gender identity. Gender dysphoria is a known condition that is accepted by major medical and psychological associations and has been identified to cause anxiety, depression and suicidal ideation when it is not addressed. There are no new or experimental medications with transgender HRT; it is prescribed the same hormones that cisgender patients are prescribed due to other medical reasons.

Transfeminine HRT usually includes estrogen and drugs that inhibit the action of testosterone. In the long run, it can result in the formation of the breast, softening of the skin, a shift in fat distribution, a decrease in body hair, and emotional relief. Testosterone Transmasculine HRT may lead to deepening of the voice, growing facial and body hair, growing muscle mass, fat redistribution, and halting of menstrual cycles. These are gradual changes, not immediate and time changes take place extending across months and years, and the degree of change differs among individuals. Part of the effects are reversible, and others could be irreversible; hence, informed consent and medical supervision are necessary.

Medical studies have continuously demonstrated that when transgender individuals undergo medical intervention through HRT, they become better mentally. The levels of depression, anxiety, and suicidal ideation are lower in the case of adequate availability of hormone therapy. It is not a transformation in the identity of the person that leads to these advantages, but a way of alleviating the long-term suffering of having a body that does not seem to belong to the individual. Any medical intervention is risky, but the risk of HRT will be determined by the dosage, age, mode of delivery and medical history of the individual. HRT is safe when it is prescribed and followed by trained doctors taking blood tests regularly, as it is one of the safest drugs, as recommended by major medical institutions.

Gender-affirming therapy is not to be confused with medical transition, but it is a distinct type of mental health care that is conducted through talk. It is aimed at assisting people to discover their emotions regarding gender, overcome stress or dysphoria, and make conscious choices in their lives. Gender-affirming therapy is not coercing anyone to transit and neither is it subject to hormonal prescription. Individuals are at liberty to enquire, pause, proceed or opt not to make any transition whatever. It is centred on emotional wellbeing, clarity and safety, rather than on pressure or pre-determined results.

Transgender hormone therapy is not a new concept, and HRT has a long history of use, but it is still viewed differently in the general discourse. When cisgender individuals obtain hormones, it is perceived as a normal medical treatment. The fact that transgender individuals are given the same hormones is often questioned or politicised. This distinction does not lie in medical science but in social attitudes and misconceptions. Regardless of the type of HRT, the hormones utilised, the methods of monitoring, and the medical principles of HRT are similar.

After all, Hormone Replacement Therapy is concerned with alleviation of pain and enhancement of life. It does not alter the type of people that they are. Rather, it assists their bodies to work in such a manner that promotes physical wellness and mental stability. HRT is a medical tool with decades of research and clinical use based on a variety of applications in menopause, thyroid disorders, cancer recovery, and gender dysphoria. Being given in a conscientious and caring way, it helps individuals to lead healthier, more stable and satisfying lives.

References

• American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Washington, DC: APA.
• American Medical Association (2021). Health care needs of transgender patients. AMA Policy Statements.
• Belch, G. E., & Belch, M. A. (2004). Advertising and Promotion: An Integrated Marketing Communications Perspective. New York: McGraw-Hill.
• Coleman, E., et al. (2022). Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. World Professional Association for Transgender Health (WPATH).
• Hembree, W. C., et al. (2017). Endocrine treatment of gender-dysphoric/gender-incongruent persons. The Journal of Clinical Endocrinology & Metabolism
• Mayo Clinic (2023). Hormone replacement therapy: Benefits and risks. Mayo Clinic Proceedings.
• National Health Service (NHS) (2022). Hormone replacement therapy (HRT). United Kingdom Department of Health.
• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2021). Thyroid hormone treatment. U.S. Department of Health and Human Services.
• World Health Organisation (2019). International Classification of Diseases (ICD-11). Geneva: WHO.
• World Health Organisation (2020). Gender incongruence in ICD-11. Geneva: WHO

.    .    .